Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) was down 0.6% during trading on Friday . The stock traded as low as $17.45 and last traded at $17.45. 1,400 shares were traded during mid-day trading, a decline of 34% from the average daily volume of 2,108 shares. The stock had previously closed at $17.55.
Shionogi & Co., Ltd. Stock Performance
The firm’s 50 day moving average is $17.83 and its two-hundred day moving average is $19.54.
About Shionogi & Co., Ltd.
Shionogi & Co, Ltd. is a research-driven pharmaceutical company headquartered in Osaka, Japan, with origins dating back to 1878. The company concentrates on the discovery, development and sale of prescription medicines in key therapeutic areas, including infectious diseases, pain management, cardiovascular and metabolic disorders, central nervous system disorders and oncology. Shionogi’s mission emphasizes addressing unmet medical needs, particularly in the field of antimicrobial resistance, where it has developed both small-molecule antibiotics and novel treatment approaches.
The firm’s product portfolio comprises marketed therapies such as Cresemba (isavuconazole) for invasive fungal infections, and Fetroja (cefiderocol), a siderophore cephalosporin antibiotic for multidrug-resistant Gram-negative infections.
See Also
- Five stocks we like better than Shionogi & Co., Ltd.
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
